Stocks · News reference
This Albemarle Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Analysts upgraded ALB, LQDA, WY, RAL, setting or revising price targets to $130, $70, $25, $88.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Mizuho Upgrades Albemarle to Outperform, Maintains Price Target to $130
Mizuho analyst John Roberts upgrades Albemarle (NYSE:ALB) from Neutral to Outperform and maintains the price target from $130 to $130.
Barclays Initiates Coverage On Albemarle with Equal-Weight Rating, Announces Price Target of $109
Barclays analyst Aleksey Yefremov initiates coverage on Albemarle (NYSE:ALB) with a Equal-Weight rating and announces Price Target of $109.
What's Going On With Docusign Stock Wednesday?
Docusign (DOCU) stock jumped 2%+, approaching its $75 52-week high despite broader tech declines. Expanded Salesforce deal boosts momentum.
Dan Ives Says AI Stock Selloff ‘Opportunity to Own the Winners’: Here Are 7 Companies He Named
In a recent interview, Dan Ives names seven stocks for investors to consider buying with the market pulling back.
Docusign Expands Salesforce Partnership, Making IAM Platform Natively Available To All AI Agents Across Salesforce And Slack
Docusign (NASDAQ:DOCU) today announced the next chapter in its more than 20-year partnership with Salesforce (NYSE:CRM). The expanded partnership brings the Docusign Intelligent Agreement Management (IAM) platform